PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (January 10 - 14, 2022)

PharmaShots Weekly Snapshots (January 10 - 14, 2022)

January 14, 2022

Ascendis Pharma’s TransCon hGH Receives EC’s Approval for Pediatric Growth Hormone Deficiency

Ascendis Pharma’s TransCon hGH Receives EC’s Approval for Pediatric Growth Hormone Deficiency

January 14, 2022

Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced or Metastatic Solid Tumors

Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced o...

January 14, 2022

RedHill Biopharma Reported New Data From a Prespecified Analysis of All Oral Opaganib's P-II/III Study in Severely Ill Hospitalized COVID-19 Patients.

RedHill Biopharma Reported New Data From a Prespecified Analysis of All Oral Opaganib's P-II/III Study in Severely Ill Hospitalize...

January 14, 2022

Everest Medicines and Singapore's EDDC Enters into a Global Licensing Agreement to Develop and Commercialize EDDC’s 3CL Protease Inhibitors as COVID-19 Oral Antiviral Treatments Worldwide

Everest Medicines and Singapore's EDDC Enters into a Global Licensing Agreement to Develop and Commercialize EDDC’s 3CL Protease I...

January 14, 2022

BridgeBio and Amgen Entered into a Non-Exclusive Clinical Collaboration for BBP-398 in P-I/II Study for Advanced Solid Tumors

BridgeBio and Amgen Entered into a Non-Exclusive Clinical Collaboration for BBP-398 in P-I/II Study for Advanced Solid Tumors

January 14, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us